Three Year Real‐life Outcomes From the Use of the Fluocinolone Acetonide Implant (Iluvien) in the Treatment of Refractory DMO

Acta Ophthalmologica - United States
doi 10.1111/aos.13972_216
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Wiley

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy